Natco Pharma shares rose almost 5% in morning trade following the announcement of its Q4 results. The share price opened at ₹1108.95 on the BSE, significantly higher than the previous close of ₹1029.20. On the NSE, the share price touched highs of ₹1100, nearing its 52-week high.
Natco Pharma reported a net profit of ₹386.3 crore for the January to March 2024 quarter, a 40% increase from ₹276 crore in the same period last year. This also marked an 81% rise from the ₹212.7 crore profit reported in the December 2023 quarter. The improvement was driven by strong operating performance, with EBITDA growing 46% to ₹491 crore from ₹336 crore a year ago.
Revenue for the quarter increased by 19% year-on-year to ₹1068.3 crore, up from ₹898 crore in the previous year. With today’s gains, Natco Pharma shares have climbed almost 70% in the past year, providing substantial returns for investors.
As of 10:12 am the shares were trading 3.21% higher at ₹1,062.40 on NSE.
